Internal Medicine, Allergy & Immunology · Saint Louis, MO
NPI
1669633889
Since 2008
Specialty
Internal Medicine, Allergy & Immunology
Code 207RA0201X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
5201 Mid America Plz, Div Im Allergy and Immunology, Ste 2300
Saint Louis, MO, 63129
Phone (314) 996-8670
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
64,944 services
Medicare patients, 2024
531
Average age 70
Drug cost, 2024
$710K
1,479 prescriptions
Company payments, 2025
$1,383
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jennifer M Monroy was code J3380 (injection, vedolizumab, intravenous, 1 mg), 9,600 times for 12 patients. In total Jennifer M Monroy billed 64,944 services in 73 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 9,600 | 12 | $16.93 | $163K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 7,980 | 25 | $8.56 | $68K |
| J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 6,260 | 27 | $37.90 | $237K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 5,650 | 14 | $8.99 | $51K |
| J0897 Injection, denosumab, 1 mg | Office | 5,520 | 87 | $20.24 | $112K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 3,250 | 12 | $33.81 | $110K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 2,850 | 15 | $24.89 | $71K |
| 95004 Test - Miscellaneous | Office | 724 | 16 | $2.76 | $2,000 |
| 95165 Treatment - Miscellaneous | Office | 340 | 18 | $10.96 | $3,727 |
| 96365 Intravenous Infusion, Hydration | Office | 301 | 111 | $44.20 | $13K |
| 95018 Test - Miscellaneous | Office | 252 | 29 | $14.74 | $3,714 |
| 96366 Intravenous Infusion, Hydration | Office | 248 | 49 | $14.70 | $3,646 |
| 96372 Injection Administration | Office | 227 | 135 | $9.38 | $2,129 |
| 95024 Test - Miscellaneous | Office | 195 | 14 | $5.69 | $1,111 |
| 99214 Office E&M - Established | Office | 170 | 120 | $90.00 | $15K |
By year: 2022 $895K for 43,056 services; 2023 $1.2M for 59,944 services; 2024 $1.3M for 64,944 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer M Monroy prescribed most often to Medicare patients was Ipratropium Bromide, with 169 prescriptions and refills. In total Jennifer M Monroy wrote 1,479 Medicare prescriptions that cost $710K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ipratropium Bromide Generic | 169 | 242 | 47 | $5,341 |
| Montelukast Sodium Generic | 149 | 358 | 43 | $1,457 |
| Fluticasone Propionate Generic | 103 | 217 | 36 | $1,803 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 73 | 79 | 22 | $1,911 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 66 | 84 | Under 11 | $54K |
| Epinephrine Generic | 56 | 56 | 41 | $10K |
| Dupixent Pen Dupilumab | 55 | 55 | Under 11 | $215K |
| Azelastine Hcl Generic | 48 | 85 | 16 | $1,574 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 45 | 45 | Under 11 | $562 |
| Cromolyn Sodium Generic | 45 | 59 | 14 | $24K |
| Prednisone Generic | 43 | 43 | 28 | $115 |
| Levocetirizine Dihydrochloride Generic | 40 | 80 | 13 | $835 |
| Famotidine Generic | 39 | 77 | 15 | $648 |
| Xolair Omalizumab | 35 | 38 | Under 11 | $130K |
| Dupixent Syringe Dupilumab | 32 | 33 | Under 11 | $125K |
Brand drugs: - claims; generic drugs: 965 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jennifer M Monroy $1,383 ($1,383 in general payments such as food, travel and fees) from 3 companies. The largest payer was CSL Behring with $1,261.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.